APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vascular Endothelial Growth Factor (VEGF) Antibodies

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Analysis and Forecast 2026-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchVascular Endothelial Growth Factor (VEGF) Antibodies Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Endothelial Growth Factor (VEGF) Antibodies Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Endothelial Growth Factor (VEGF) Antibodies Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Vascular Endothelial Growth Factor (VEGF) Antibodies market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vascular Endothelial Growth Factor (VEGF) Antibodies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vascular Endothelial Growth Factor (VEGF) Antibodies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vascular Endothelial Growth Factor (VEGF) Antibodies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vascular Endothelial Growth Factor (VEGF) Antibodies is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vascular Endothelial Growth Factor (VEGF) Antibodies include Sanofi, Novartis, Merck, Roche, Eli Lilly, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vascular Endothelial Growth Factor (VEGF) Antibodies, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vascular Endothelial Growth Factor (VEGF) Antibodies, also provides the sales of main regions and countries. Of the upcoming market potential for Vascular Endothelial Growth Factor (VEGF) Antibodies, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vascular Endothelial Growth Factor (VEGF) Antibodies sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vascular Endothelial Growth Factor (VEGF) Antibodies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vascular Endothelial Growth Factor (VEGF) Antibodies sales, projected growth trends, production technology, application and end-user industry.

Vascular Endothelial Growth Factor (VEGF) Antibodies Segment by Company

Sanofi

Novartis

Merck

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Regeneron

Bristol-Myer Squibb

Boehringer Ingelheim

Abcam Plc

Vascular Endothelial Growth Factor (VEGF) Antibodies Segment by Type

Aflibercept

Bevacizumab

Ranibizumab

Others

Vascular Endothelial Growth Factor (VEGF) Antibodies Segment by Application

Specialty Clinics

Hospitals

Ambulatory Surgical Centers

Cancer Research Institutes

Others

Vascular Endothelial Growth Factor (VEGF) Antibodies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Endothelial Growth Factor (VEGF) Antibodies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Endothelial Growth Factor (VEGF) Antibodies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Endothelial Growth Factor (VEGF) Antibodies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vascular Endothelial Growth Factor (VEGF) Antibodies in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vascular Endothelial Growth Factor (VEGF) Antibodies manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vascular Endothelial Growth Factor (VEGF) Antibodies sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Aflibercept Major Manufacturers Table 3. Bevacizumab Major Manufacturers Table 4. Ranibizumab Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Specialty Clinics Major Manufacturers Table 8. Hospitals Major Manufacturers Table 9. Ambulatory Surgical Centers Major Manufacturers Table 10. Cancer Research Institutes Major Manufacturers Table 11. Others Major Manufacturers Table 12. Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Trends Table 13. Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Drivers Table 14. Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Opportunities and Challenges Table 15. Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Restraints Table 16. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region (2021-2026) Table 20. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region (2027-2032) Table 21. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 22. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2021-2026) & (W Units) Table 23. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2027-2032) & (W Units) Table 24. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2021-2026) Table 25. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2027-2032) Table 26. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Manufacturers (2021-2026) Table 30. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers, Product Type & Application Table 34. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Vascular Endothelial Growth Factor (VEGF) Antibodies by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type (2021-2026) Table 41. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type (2027-2032) Table 42. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 43. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 44. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2027-2032) & (W Units) Table 45. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2021-2026) Table 46. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2027-2032) Table 47. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2021-2026) & (US$/Unit) Table 48. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2027-2032) & (US$/Unit) Table 49. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application (2021-2026) Table 53. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application (2027-2032) Table 54. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 55. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 56. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2027-2032) & (W Units) Table 57. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2021-2026) Table 58. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2027-2032) Table 59. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2021-2026) & (US$/Unit) Table 60. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2027-2032) & (US$/Unit) Table 61. Sanofi Company Information Table 62. Sanofi Business Overview Table 63. Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 65. Sanofi Recent Development Table 66. Novartis Company Information Table 67. Novartis Business Overview Table 68. Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 70. Novartis Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 75. Merck Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 80. Roche Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 85. Eli Lilly Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 90. Pfizer Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Bayer Company Information Table 97. Bayer Business Overview Table 98. Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 100. Bayer Recent Development Table 101. AstraZeneca Company Information Table 102. AstraZeneca Business Overview Table 103. AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 105. AstraZeneca Recent Development Table 106. Regeneron Company Information Table 107. Regeneron Business Overview Table 108. Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 110. Regeneron Recent Development Table 111. Bristol-Myer Squibb Company Information Table 112. Bristol-Myer Squibb Business Overview Table 113. Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 115. Bristol-Myer Squibb Recent Development Table 116. Boehringer Ingelheim Company Information Table 117. Boehringer Ingelheim Business Overview Table 118. Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 120. Boehringer Ingelheim Recent Development Table 121. Abcam Plc Company Information Table 122. Abcam Plc Business Overview Table 123. Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 125. Abcam Plc Recent Development Table 126. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 129. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2027-2032) & (W Units) Table 130. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 131. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 132. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 135. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2027-2032) & (W Units) Table 136. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 137. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 138. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 142. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 143. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2027-2032) & (W Units) Table 144. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Country (2021-2026) & (US$/Unit) Table 145. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Country (2027-2032) & (US$/Unit) Table 146. United States Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 147. Canada Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 148. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 149. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 150. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 151. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2027-2032) & (W Units) Table 152. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 153. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 154. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 155. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 156. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 157. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2027-2032) & (W Units) Table 158. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 159. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 162. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 163. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 164. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 165. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2027-2032) & (W Units) Table 166. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Country (2021-2026) & (US$/Unit) Table 167. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Country (2027-2032) & (US$/Unit) Table 168. Germany Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 169. France Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 170. U.K. Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 171. Italy Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 173. China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 174. China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 175. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 176. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2027-2032) & (W Units) Table 177. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 178. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 179. China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 180. China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 181. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 182. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2027-2032) & (W Units) Table 183. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 184. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 185. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 186. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 187. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 188. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2027-2032) & (W Units) Table 189. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 190. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 191. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 192. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 193. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 194. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2027-2032) & (W Units) Table 195. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 196. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 197. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 201. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 202. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2027-2032) & (W Units) Table 203. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Country (2021-2026) & (US$/Unit) Table 204. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Country (2027-2032) & (US$/Unit) Table 205. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 206. South Korea Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 207. India Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 208. Australia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 209. China Taiwan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 210. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 211. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2026) & (US$ Million) Table 212. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2027-2032) & (US$ Million) Table 213. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 214. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2027-2032) & (W Units) Table 215. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2021-2026) & (US$/Unit) Table 216. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Type (2027-2032) & (US$/Unit) Table 217. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2026) & (US$ Million) Table 218. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2027-2032) & (US$ Million) Table 219. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 220. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2027-2032) & (W Units) Table 221. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2021-2026) & (US$/Unit) Table 222. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Application (2027-2032) & (US$/Unit) Table 223. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 224. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 225. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 226. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 227. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 228. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2027-2032) & (W Units) Table 229. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Country (2021-2026) & (US$/Unit) Table 230. SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Country (2027-2032) & (US$/Unit) Table 231. Brazil Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 232. Argentina Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 233. Chile Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 234. Colombia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 235. Peru Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 236. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 237. Israel Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 238. UAE Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 239. Turkey Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 240. Iran Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 241. Egypt Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Table 242. Key Raw Materials Table 243. Raw Materials Key Suppliers Table 244. Vascular Endothelial Growth Factor (VEGF) Antibodies Distributors List Table 245. Vascular Endothelial Growth Factor (VEGF) Antibodies Customers List Table 246. Research Programs/Design for This Report Table 247. Authors List of This Report Table 248. Secondary Sources Table 249. Primary Sources List of Figures Figure 1. Vascular Endothelial Growth Factor (VEGF) Antibodies Image Figure 2. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Share 2021 VS 2025 VS 2032 Figure 4. Aflibercept Image Figure 5. Bevacizumab Image Figure 6. Ranibizumab Image Figure 7. Others Image Figure 8. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Share 2021 VS 2025 VS 2032 Figure 10. Specialty Clinics Image Figure 11. Hospitals Image Figure 12. Ambulatory Surgical Centers Image Figure 13. Cancer Research Institutes Image Figure 14. Others Image Figure 15. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2032) & (US$ Million) Figure 17. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region (2021-2032) Figure 20. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (2021-2032) & (W Units) Figure 21. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 22. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Vascular Endothelial Growth Factor (VEGF) Antibodies Sales YoY (2021-2032) & (W Units) Figure 24. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales YoY (2021-2032) & (W Units) Figure 25. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales YoY (2021-2032) & (W Units) Figure 26. Asia (Excluding China) Vascular Endothelial Growth Factor (VEGF) Antibodies Sales YoY (2021-2032) & (W Units) Figure 27. South America, Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales YoY (2021-2032) & (W Units) Figure 28. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type (2021-2032) Figure 34. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 35. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2021-2032) Figure 37. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application (2021-2032) Figure 40. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 41. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2021-2032) Figure 43. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Type (2021-2032) Figure 44. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Type (2021-2032) Figure 45. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Application (2021-2032) Figure 46. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Application (2021-2032) Figure 47. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Country (2021-2032) Figure 48. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Country (2021-2032) Figure 49. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Type (2021-2032) Figure 50. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Type (2021-2032) Figure 51. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Application (2021-2032) Figure 52. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Application (2021-2032) Figure 53. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Country (2021-2032) Figure 54. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Country (2021-2032) Figure 55. China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Type (2021-2032) Figure 56. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Type (2021-2032) Figure 57. China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Application (2021-2032) Figure 58. China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Application (2021-2032) Figure 59. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Share by Type (2021-2032) Figure 60. Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Type (2021-2032) Figure 61. Asia Va

Scope & coverage.

Types
  • Aflibercept
  • Bevacizumab
  • Ranibizumab
  • Others
Applications
  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Others
Companies covered
  • Sanofi
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Regeneron
  • Bristol-Myer Squibb
  • Boehringer Ingelheim
  • Abcam Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Type
  3. 1.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Aflibercept
  5. 1.2.3 Bevacizumab
  6. 1.2.4 Ranibizumab
  7. 1.2.5 Others
  8. 1.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Application
  9. 1.3.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Specialty Clinics
  11. 1.3.3 Hospitals
  12. 1.3.4 Ambulatory Surgical Centers
  13. 1.3.5 Cancer Research Institutes
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Vascular Endothelial Growth Factor (VEGF) Antibodies Market Dynamics
  1. 2.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Trends
  2. 2.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Drivers
  3. 2.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Opportunities and Challenges
  4. 2.4 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region
  3. 3.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2021-2026)
  5. 3.2.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2027-2032)
  6. 3.2.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region
  9. 3.4.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2021-2026)
  11. 3.4.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2027-2032)
  12. 3.4.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Manufacturers
  2. 4.1.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Manufacturers
  6. 4.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers, Product Type & Application
  13. 4.7 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market CR5 and HHI
  16. 4.8.2 2025 Vascular Endothelial Growth Factor (VEGF) Antibodies Tier 1, Tier 2, and Tier 3
5 Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Type
  1. 5.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type
  2. 5.1.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type
  6. 5.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type
6 Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Application
  1. 6.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application
  2. 6.1.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application
  6. 6.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Eli Lilly
  26. 7.5.1 Eli Lilly Company Information
  27. 7.5.2 Eli Lilly Business Overview
  28. 7.5.3 Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  30. 7.5.5 Eli Lilly Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 AstraZeneca
  50. 7.9.1 AstraZeneca Company Information
  51. 7.9.2 AstraZeneca Business Overview
  52. 7.9.3 AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  54. 7.9.5 AstraZeneca Recent Developments
  55. 7.10 Regeneron
  56. 7.10.1 Regeneron Company Information
  57. 7.10.2 Regeneron Business Overview
  58. 7.10.3 Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  60. 7.10.5 Regeneron Recent Developments
  61. 7.11 Bristol-Myer Squibb
  62. 7.11.1 Bristol-Myer Squibb Company Information
  63. 7.11.2 Bristol-Myer Squibb Business Overview
  64. 7.11.3 Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  66. 7.11.5 Bristol-Myer Squibb Recent Developments
  67. 7.12 Boehringer Ingelheim
  68. 7.12.1 Boehringer Ingelheim Company Information
  69. 7.12.2 Boehringer Ingelheim Business Overview
  70. 7.12.3 Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  72. 7.12.5 Boehringer Ingelheim Recent Developments
  73. 7.13 Abcam Plc
  74. 7.13.1 Abcam Plc Company Information
  75. 7.13.2 Abcam Plc Business Overview
  76. 7.13.3 Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  78. 7.13.5 Abcam Plc Recent Developments
8 North America
  1. 8.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Type
  2. 8.1.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2032)
  3. 8.1.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2032)
  4. 8.1.3 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2021-2032)
  5. 8.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Application
  6. 8.2.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2032)
  7. 8.2.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2032)
  8. 8.2.3 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2021-2032)
  9. 8.3 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  10. 8.3.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Type
  2. 9.1.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2032)
  4. 9.1.3 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2021-2032)
  5. 9.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Application
  6. 9.2.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2032)
  8. 9.2.3 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2021-2032)
  9. 9.3 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  10. 9.3.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Type
  2. 10.1.1 China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2032)
  3. 10.1.2 China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2032)
  4. 10.1.3 China Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2021-2032)
  5. 10.2 China Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Application
  6. 10.2.1 China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2032)
  7. 10.2.2 China Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2032)
  8. 10.2.3 China Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Type
  2. 11.1.1 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2032)
  4. 11.1.3 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2021-2032)
  5. 11.2 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Application
  6. 11.2.1 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2032)
  8. 11.2.3 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2021-2032)
  9. 11.3 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  10. 11.3.1 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Type
  2. 12.1.1 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2021-2032)
  5. 12.2 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Application
  6. 12.2.1 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2021-2032)
  9. 12.3 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  10. 12.3.1 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Value Chain Analysis
  2. 13.1.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vascular Endothelial Growth Factor (VEGF) Antibodies Production Mode & Process
  6. 13.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Distributors
  9. 13.2.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst